Huntsman Cancer Institute At University Of Utah

Survivors of cancer in adolescence and young adulthood face increased risk for subsequent HPV-related cancer diagnoses, according to research conducted at University of Utah’s Huntsman Cancer Institute.

FDA approved talazoparib plus enzalutamide for treatment of homologous recombination repair gene-mutated metastatic castration-resistant prostate cancer.

Although an artificial intelligence chatbot provided accurate information about cancer in most cases, some of its responses could be misinterpreted, according to researchers at University of Utah Huntsman Cancer Institute.

A nurse-created algorithm helped determine which patients with multiple myeloma exhibited the highest risk for pneumonia, according to study results.

Given the proliferation of consumer-facing health information online, clinicians often find themselves addressing potentially harmful cancer misinformation with their patients.

SAN FRANCISCO — The addition of talazoparib to first-line enzalutamide extended imaging-based PFS among men with metastatic castration-resistant prostate cancer, according to results of the randomized phase 3 TALAPRO-2 study.

Moderate exercise may improve longevity for patients with colorectal cancer by acting on the gut microbiome, according to a study published in American Journal of Cancer Research.

Approximately 83% of children, adolescents and young adults within the continental United States have access to pediatric cancer care within a 60-minute travel distance, according to a study published in JAMA Network Open.

ASH recognized three Choosing Wisely champions and three guideline implementation champions at this year’s ASH Annual Meeting and Exposition.

In this video, Srinivas K. Tantravahi, MBBS, MRCP(UK), discussed a case study, presented at the 14th International Congress on Myeloproliferative Neoplasms, of dizygotic twins.